BR112018008388A2 - composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso - Google Patents

composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso

Info

Publication number
BR112018008388A2
BR112018008388A2 BR112018008388A BR112018008388A BR112018008388A2 BR 112018008388 A2 BR112018008388 A2 BR 112018008388A2 BR 112018008388 A BR112018008388 A BR 112018008388A BR 112018008388 A BR112018008388 A BR 112018008388A BR 112018008388 A2 BR112018008388 A2 BR 112018008388A2
Authority
BR
Brazil
Prior art keywords
bone
kit
matrix
composition
improved transfer
Prior art date
Application number
BR112018008388A
Other languages
English (en)
Inventor
g wilson Christopher
Todd Brown Christopher
Vanderploeg Eric
Seeherman Howard
Wozney John
Original Assignee
Bioventus Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioventus Llc filed Critical Bioventus Llc
Publication of BR112018008388A2 publication Critical patent/BR112018008388A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Ceramic Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)

Abstract

a presente invenção refere-se a sistemas e métodos para preparo de enxertos ósseos sintéticos osteoindutores em que um grânulo cerâmico poroso, que pode ser incorporado em um material de matriz biocompatível, é carregado com um agente osteoindutor. o carregamento de grânulos é facilitado em alguns casos pelo uso de tampões e pré-tratamentos de baixo ph.
BR112018008388A 2015-10-30 2016-10-31 composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso BR112018008388A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562248861P 2015-10-30 2015-10-30
PCT/US2016/059782 WO2017075613A1 (en) 2015-10-30 2016-10-31 Matrix for enhanced delivery of osteoinductive molecules in bone repair

Publications (1)

Publication Number Publication Date
BR112018008388A2 true BR112018008388A2 (pt) 2018-10-23

Family

ID=57281306

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018008388A BR112018008388A2 (pt) 2015-10-30 2016-10-31 composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso

Country Status (9)

Country Link
US (1) US10300172B2 (pt)
EP (1) EP3368094B1 (pt)
JP (1) JP2018537158A (pt)
KR (1) KR20180079368A (pt)
CN (1) CN108601864A (pt)
AU (1) AU2016344024B2 (pt)
BR (1) BR112018008388A2 (pt)
CA (1) CA3002565A1 (pt)
WO (1) WO2017075613A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3697459T3 (pl) * 2017-10-19 2023-03-06 Genera Istrazivanja D.O.O. Autologiczny substytut przeszczepu kości
KR102094987B1 (ko) * 2019-07-12 2020-03-31 주식회사 휴덴스 합성골 이식재 제조장치
US11433159B2 (en) * 2019-07-26 2022-09-06 Warsaw Orthopedic, Inc. Hydratable and flowable implantable compositions and methods of making and using them
US11498880B2 (en) 2019-07-26 2022-11-15 Warsaw Orthopedic, Inc. Calcium phosphate granules and methods of making them
US11311647B2 (en) * 2019-07-26 2022-04-26 Warsaw Orthopedic, Inc. Implantable calcium phosphate compositions and methods
CN114569732B (zh) * 2022-01-24 2023-09-01 国家纳米科学中心 一种纳米药物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US5385887A (en) 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
EP0823687B1 (de) 1996-08-09 2001-01-31 Hans Dipl.-Ing. Seib Computernetzwerk und Verfahren zur Freigabe von Bau- und Konstruktionsplänen
EP1344538A1 (en) * 2002-03-14 2003-09-17 Degradable Solutions AG Porous biodegradable implant material and method for its fabrication
JP4540969B2 (ja) 2003-11-27 2010-09-08 Ｈｏｙａ株式会社 リン酸カルシウムセラミックス多孔体及びその製造方法
US7722895B1 (en) * 2004-09-20 2010-05-25 Warsaw Orthopedic, Inc. Osteogenic implants with combined implant materials, and materials and methods for same
GB0502493D0 (en) * 2005-02-07 2005-03-16 Orthogem Ltd Bone cement
WO2007097710A1 (en) 2006-02-27 2007-08-30 Agency For Science, Technology And Research Curable bone cement
GB2440721A (en) * 2006-08-11 2008-02-13 Univ Cambridge Tech Composite biomaterial formed by cooling a fluid composition on a porous solid and removing solidified crystals of the liquid carrier
US8048857B2 (en) * 2006-12-19 2011-11-01 Warsaw Orthopedic, Inc. Flowable carrier compositions and methods of use
WO2012028620A1 (en) 2010-08-31 2012-03-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation
BR112013014686A2 (pt) 2010-12-13 2016-10-04 Biomimetic Therapeutics Llc composições e métodos para procedimentos de fusão da espinha
BR112013021369B1 (pt) 2011-02-25 2019-04-16 Synthes Gmbh Implante e sistema de formação de um implante para promover crescimento ósseo
GB201113054D0 (en) 2011-07-29 2011-09-14 Rolls Royce Plc Flap seal and sealing apparatus
CN110464701A (zh) 2012-04-11 2019-11-19 感应生物制品股份有限公司 用于生长因子多相释放的体系和方法

Also Published As

Publication number Publication date
KR20180079368A (ko) 2018-07-10
CA3002565A1 (en) 2017-05-04
AU2016344024B2 (en) 2018-11-22
US10300172B2 (en) 2019-05-28
US20170209623A1 (en) 2017-07-27
CN108601864A (zh) 2018-09-28
WO2017075613A1 (en) 2017-05-04
JP2018537158A (ja) 2018-12-20
EP3368094B1 (en) 2021-03-10
AU2016344024A1 (en) 2018-05-10
EP3368094A1 (en) 2018-09-05

Similar Documents

Publication Publication Date Title
BR112018008388A2 (pt) composição compreendendo uma matriz para transferência melhorada de moléculas osteoindutoras em reparo ósseo, implante ósseo, kit e uso
BR112017014017A2 (pt) sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo.
BR112017016552A2 (pt) ?compósitos de polímeros sintéticos de alta resistência de camada única para válvulas protéticas?
BR112017022845A2 (pt) neoepítopos de câncer
BR112018010381A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
CR20170234A (es) Composiciones de antibiótico
BR112018011152A2 (pt) agonistas de cnp de liberação controlada com estabilidade em nep aumentada
BR112015023003A2 (pt) nucleos de disco intervertebral protético
BR122020024446B8 (pt) Compostos para modulação da expressão do receptor do hormônio de crescimento
CL2010001538A1 (es) Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de las proteinas quinasas; composicion farmaceutica; y su uso para el tratamiento del cancer, o un trastorno proliferativo celular.
CL2010001483A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune.
BR112017012974A2 (pt) cultura em suspensão de células-tronco pluripotentes
IL272674A (en) Preparations for use in the treatment or prevention of graft-versus-graft disease or diffuse nodal bleeding or venous occlusive disease associated with hematopoietic allograft transplantation
WO2014151091A3 (en) Compositions of and methods for cancellous bone matrix
EA201390612A1 (ru) Биоразлагаемая композиция для доставки лекарственного средства
BR112018011008A2 (pt) agonistas de cnp de liberação controlada com ligação a npr-c baixa
BR112016013324A8 (pt) cimento substituto de enxerto de osso e composição de partículas adaptada para formação do mesmo
PH12021551100A1 (en) Dried biological compositions and methods thereof
BR112014013149A2 (pt) peça moldada, material granular, método para produzir um material granular e uso de uma peça moldada
CL2012002887A1 (es) Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer.
BR112012017136A2 (pt) Composição farmacêutica compreendendo 3-beta- hidróxi-5-alfa-pregnan-20-ona com propriedades de armazenamento e solubidade aperfeiçoadas.
BR112017014107A2 (pt) composição nutricional útil no tratamento de pacientes com ibd
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
BR102016007036A8 (pt) material de reparo de tecido derivado de pele de peixe e método de fabricação do mesmo
BR112019023898A2 (pt) método para tratamento de câncer gástrico, uso de um anticorpo e composição

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired